For personal use. Only reproduce with permission from The Lancet Publishing Group. E rstwhile hopes that severe acute respiratory syndrome (SARS) can somehow be eradicated seem to be dissipating as infectious disease experts told delegates at a SARS symposium in Canada that the virus has probably found a permanent home in the world's virological catalogue.
"In terms of the consensus, it seems to be that people do agree with the fact, certainly worldwide, that SARS is something that we will have to live with, the fact that the new infectious disease is likely in the world to stay", Paul Gully, senior director-general of Health Canada's Population and Public Health Branch told a press conference at the conclusion of the April 30-May 1 gathering in Toronto.
"These types of microbes just don't disappear. They don't go away", added Stephen Ostroff, associate director of the US Centers for Disease Control (CDC).
In taking stock of Canadian lessons learned, delegates were also apprised of the importance of early detection and rapid quarantine of suspected cases. In Vancouver, where a quick-witted doctor quickly isolated a patient showing symptoms of the mysterious disease, there have only been four probable and 67 suspected cases of SARS. In Toronto, where the first case was not so quickly isolated, the toll was much heavier, especially in hospitals.
The conference concluded with Canadian officials claiming to have garnered the necessary information from which to develop a national strategy for containing SARS. Although they didn't release the draft plan, officials indicated the strategy will probably feature the creation of a national centre for disease control similar to the CDC.
CDC director Julie Gerberding argued it might be equally judicious to develop a joint North American strategy for containing SARS and ultimately, "a global strategy."
Officials also stressed that international collaboration and cooperation lie at the core of containing the disease and, almost ironically, praised Canada as a "model of transparency" for its willingness to share SARS information.
Yet that transparency had led WHO to issue an advisory against travel to Toronto a week before the conference (see Lancet 2003; 361: 1525). Some Canadian infectious disease experts said Canada was included because WHO wanted to appease China by including a western city in its list of dangerous destinations.
1 week later, and only 1 day before the conference, WHO lifted the advisory after conceding they might have been a trifle hasty in imposing it, especially since it appeared the corner had already been turned on containing SARS in Toronto.
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ultimately prompt countries to avoid reporting outbreaks for fear of having the same economic fallout that struck the Canadian city. WHO director of communicable-disease surveillance and response Guenael Rodier conceded the possibility in a letter to the Canadian Medical Association Journal, saying that, "we are aware, too, that some countries, looking at the example of Toronto, may choose to be less open and frank in their reporting of SARS-or any other epidemic-prone disease with the potential for international spread-for fear of the economic consequences".
But WHO director general for communicable diseases David Heymann argued that such secrecy would be ill-advised. "Everyone today understands that an infectious disease in one country is a problem for us all."
Meanwhile, WHO published studies suggesting that the possibility of environmental transmission of SARS might be higher than originally believed because the virus is more resistant than other known human coronaviruses. The studies, undertaken by members of the WHO multicentre collaborative network on SARS diagnosis, indicate that the virus can survive in faeces and urine for up to 2 days. It can survive in stools from diarrhoea patients, which is more acidic, for up to 4 days. The virus can also survive on plastic surfaces for 2 days and withstand cold for up to 3 weeks at 4°C and -80°C.
The results suggest the virus might be transmitted by touching contaminated objects like door handles or hospital surfaces, and not strictly as a result of infected people having coughed or sneezed on others.
Worldwide, the death toll from SARS stood at 461 on May 3, with the number of probable cases at 6583 in 27 countries. The gravest consequences continue to be felt in China, with more than 13 688 Beijing residents having been placed in quarantine. China is also struggling with growing signs of social unrest as a result of the disease, while its health care system is straining to cope with the heavy SARS toll within its ranks. Nearly 20% of cases in Beijing have occurred among hospital workers. Some 20 of the 114 new probable cases reported May 3 in Beijing were healthcare workers.
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